Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of central venous versus peripheral cyclosporine sampling during intravenous administration
NL-OMON50893Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of cyclosporine in Hematopathy, sponsored by Erasmus MC. Primary endpoint: Difference between cyclosporine levels in central venous versus peripheral blood samples. Started Apr 2021; status: active, not recruiting.
02
Drugs
cyclosporine
03
Conditions
Hematopathy
Beyond the preview
Go deeper on NL-OMON50893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50893.